Dr. Laura Guay serves a dual appointment as vice president for research at the Elizabeth Glaser Pediatric AIDS Foundation and research professor at The George Washington University (GWU) Milken Institute School of Public Health. Dr. Guay received her M.D. from GWU in 1985, and went on to a pediatrics residency at Rainbow Babies & Children’s Hospital and Case Western Reserve University (CWRU) in Cleveland, Ohio. Dr. Guay was a visiting lecturer at Makerere University in Kampala, Uganda, from 1988 to 1991, and then returned to CWRU to complete her fellowship in pediatric infectious diseases. She then spent seven more years in Uganda, where she worked on the landmark HIVNET 012 trial, which determined the effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV. Prior to joining GWU, Dr. Guay was a member of the faculty of the Johns Hopkins University School of Medicine. Her previous research focused on identifying interventions to reduce the rate of HIV transmission in breast-feeding infants and on the testing of an HIV vaccine in infants. Her current work focuses on how to translate the key scientific breakthroughs in HIV prevention and treatment in women and children into the field in settings with limited resources and infrastructure. In addition to her EGPAF and GWU activities, Dr. Guay currently serves as an invited member of several advisory groups including the NIAID HIV/AIDS Strategic Working Group, the scientific technical advisory committee for the International AIDS Society Collaborative Initiative for Pediatric Education and Research and as steering committee member for the NIH-PEPFAR Adolescent HIV Prevention and Treatment Implementation Science Alliance. Previously she served on the President’s Emergency Plan for AIDS Relief (PEPFAR) Expert Panel on the Prevention of Mother-to-Child HIV Transmission, the PEPFAR Scientific Advisory Board, technical consultations to WHO on PMTCT Guidelines and NIH-PEPFAR PMTCT Implementation Science Alliance.